These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 16178043)
1. Differences in antihypertensive drug persistence associated with drug class and gender: a PHARMO study. Erkens JA; Panneman MM; Klungel OH; van den Boom G; Prescott MF; Herings RM Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):795-803. PubMed ID: 16178043 [TBL] [Abstract][Full Text] [Related]
2. Antihypertensive persistence and drug class. Marentette MA; Gerth WC; Billings DK; Zarnke KB Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422 [TBL] [Abstract][Full Text] [Related]
3. Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study. Bourgault C; Sénécal M; Brisson M; Marentette MA; Grégoire JP J Hum Hypertens; 2005 Aug; 19(8):607-13. PubMed ID: 15920457 [TBL] [Abstract][Full Text] [Related]
5. Long-term persistence with antihypertensive drugs in new patients. Degli Esposti E; Sturani A; Di Martino M; Falasca P; Novi MV; Baio G; Buda S; Volpe M J Hum Hypertens; 2002 Jun; 16(6):439-44. PubMed ID: 12037702 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and management of hypertension in primary care in Portugal. Insights from the VALSIM study. Cortez-Dias N; Martins S; Belo A; Fiuza M; Rev Port Cardiol; 2009 May; 28(5):499-523. PubMed ID: 19650569 [TBL] [Abstract][Full Text] [Related]
7. Uptake of angiotensin II receptor blockers in the treatment of hypertension. Greving JP; Denig P; van der Veen WJ; Beltman FW; Sturkenboom MC; de Zeeuw D; Haaijer-Ruskamp FM Eur J Clin Pharmacol; 2005 Jul; 61(5-6):461-6. PubMed ID: 15912393 [TBL] [Abstract][Full Text] [Related]
8. The relationship between antihypertensive combination therapies comprising diuretics and/or beta-blockers and the risk of new-onset diabetes: a retrospective longitudinal cohort study. Liou YS; Ma T; Tien L; Lin CM; Jong GP Hypertens Res; 2009 Jun; 32(6):496-9. PubMed ID: 19390541 [TBL] [Abstract][Full Text] [Related]
9. Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy. Patel BV; Remigio-Baker RA; Thiebaud P; Preblick R; Plauschinat C BMC Fam Pract; 2008 Nov; 9():61. PubMed ID: 18990240 [TBL] [Abstract][Full Text] [Related]
10. Antihypertensive drug persistence and compliance among newly treated elderly hypertensives in ontario. Friedman O; McAlister FA; Yun L; Campbell NR; Tu K; Am J Med; 2010 Feb; 123(2):173-81. PubMed ID: 20103027 [TBL] [Abstract][Full Text] [Related]
11. Antihypertensive drugs and new-onset diabetes: a retrospective longitudinal cohort study. Jong GP; Chang MH; Tien L; Li SY; Liou YS; Lung CH; Ma T Cardiovasc Ther; 2009; 27(3):159-63. PubMed ID: 19689614 [TBL] [Abstract][Full Text] [Related]
12. Stepped care for hypertension: are the assumptions valid? Caro JJ J Hypertens Suppl; 1997 Dec; 15(7):S35-9. PubMed ID: 9532519 [TBL] [Abstract][Full Text] [Related]
13. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction. Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916 [TBL] [Abstract][Full Text] [Related]
14. Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis. Penning-van Beest FJ; Goettsch WG; Erkens JA; Herings RM Clin Ther; 2006 Feb; 28(2):236-42. PubMed ID: 16678644 [TBL] [Abstract][Full Text] [Related]
15. Antihypertensive drug prescribing and persistence among new elderly users: implications for persistence improvement interventions. Tu K; Anderson LN; Butt DA; Quan H; Hemmelgarn BR; Campbell NR; McAlister FA; Can J Cardiol; 2014 Jun; 30(6):647-52. PubMed ID: 24882536 [TBL] [Abstract][Full Text] [Related]
16. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug. Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208 [TBL] [Abstract][Full Text] [Related]
17. The patterns of antihypertensive drug prescription by cardiologists in Kerman province of Iran, 2006. Sepehri G; Talebizadeh N; Mirzazadeh A; Mohsenbeigi M Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):180-5. PubMed ID: 18001003 [TBL] [Abstract][Full Text] [Related]
18. Prevalence, incidence and persistence of antipsychotic drug prescribing in the Italian general population: retrospective database analysis, 1999-2002. Mirandola M; Andretta M; Corbari L; Sorio A; Nosè M; Barbui C Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):412-20. PubMed ID: 16287199 [TBL] [Abstract][Full Text] [Related]
19. Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy. Corrao G; Zambon A; Parodi A; Poluzzi E; Baldi I; Merlino L; Cesana G; Mancia G J Hypertens; 2008 Apr; 26(4):819-24. PubMed ID: 18327094 [TBL] [Abstract][Full Text] [Related]
20. Compliance, persistence, and switching patterns for ACE inhibitors and ARBs. Vegter S; Nguyen NH; Visser ST; de Jong-van den Berg LT; Postma MJ; Boersma C Am J Manag Care; 2011 Sep; 17(9):609-16. PubMed ID: 21902446 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]